Department of Pre-Therapeutic Target Discovery, Regeneron Pharmaceuticals Inc, Tarrytown, NY, 10591, USA.
Palmira Biopharma, Moscow, 143026, RF, Russia.
Angiogenesis. 2020 May;23(2):179-192. doi: 10.1007/s10456-019-09696-8. Epub 2019 Nov 21.
Angiogenesis is largely driven by motile endothelial tip-cells capable of invading avascular tissue domains and enabling new vessel formation. Highly responsive to Vascular Endothelial Growth-Factor-A (VEGFA), endothelial tip-cells also suppress angiogenic sprouting in adjacent stalk cells, and thus have been a primary therapeutic focus in addressing neovascular pathologies. Surprisingly, however, there remains a paucity of specific endothelial tip-cell markers. Here, we employ transcriptional profiling and a lacZ reporter allele to identify Kcne3 as an early and selective endothelial tip-cell marker in multiple angiogenic contexts. In development, Kcne3 expression initiates during early phases of angiogenesis (E9) and remains specific to endothelial tip-cells, often adjacent to regions expressing VEGFA. Consistently, Kcne3 activation is highly responsive to exogenous VEGFA but maintains tip-cell specificity throughout normal retinal angiogenesis. We also demonstrate endothelial tip-cell selectivity of Kcne3 in several injury and tumor models. Together, our data show that Kcne3 is a unique marker of sprouting angiogenic tip-cells and offers new opportunities for investigating and targeting this cell type.
血管生成在很大程度上是由能够侵袭无血管组织区域并促进新血管形成的运动性内皮尖端细胞驱动的。内皮尖端细胞对血管内皮生长因子-A(VEGFA)高度敏感,还能抑制相邻的茎细胞中的血管生成芽生,因此一直是解决新血管病理的主要治疗重点。然而,令人惊讶的是,特异性内皮尖端细胞标志物仍然很少。在这里,我们利用转录谱分析和一个 lacZ 报告基因等位基因,鉴定出 Kcne3 是多种血管生成情况下早期和选择性的内皮尖端细胞标志物。在发育过程中,Kcne3 的表达在血管生成的早期阶段(E9)开始,并始终特异性地表达于内皮尖端细胞,通常与表达 VEGFA 的区域相邻。一致地,Kcne3 的激活对外源性 VEGFA 高度敏感,但在正常视网膜血管生成过程中始终保持尖端细胞的特异性。我们还在几种损伤和肿瘤模型中证明了 Kcne3 的内皮尖端细胞选择性。总之,我们的数据表明,Kcne3 是发芽血管生成尖端细胞的独特标志物,为研究和靶向这种细胞类型提供了新的机会。